Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020141825 - TABLET AND METHOD OF PREPARING SAME

Publication Number WO/2020/141825
Publication Date 09.07.2020
International Application No. PCT/KR2019/018684
International Filing Date 30.12.2019
IPC
A61K 9/24 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
22Sustained or differential release type
24Layered or laminated unitary dosage forms
A61K 9/20 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
A61K 31/41 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A61K 31/40 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61P 9/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
12Antihypertensives
CPC
A61K 31/40
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K 31/41
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
A61K 9/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
A61P 9/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
12Antihypertensives
Applicants
  • 보령제약 주식회사 BORYUNG PHARMACEUTICAL CO., LTD [KR]/[KR]
Inventors
  • 김윤삼 KIM, Yunsam
  • 김명식 KIM, Myung Sic
  • 신동철 SHIN, Dong Chul
  • 황용연 HWANG, Yongyoun
Agents
  • 안소영 AHN, So Young
Priority Data
10-2018-017364931.12.2018KR
Publication Language Korean (KO)
Filing Language Korean (KO)
Designated States
Title
(EN) TABLET AND METHOD OF PREPARING SAME
(FR) COMPRIMÉ ET SON PROCÉDÉ DE PRÉPARATION
(KO) 정제 및 이의 제조방법
Abstract
(EN)
The present invention relates to a tablet and a method for preparing same, wherein atorvastatin granules are adjusted to have a particle size distribution of a predetermined value or more, thereby significantly improving tableting characteristics in the process of tableting with fimasartan, leading to excellent content uniformity, so that tablets can be economically and easily mass-produced.
(FR)
La présente invention concerne un comprimé et son procédé de préparation, selon lequel des granules d'atorvastatine sont ajustés pour avoir une distribution de taille de particule d'au moins une valeur prédéterminée, ce qui permet d'améliorer considérablement les caractéristiques de compression dans le processus de fabrication de comprimés avec du fimasartan, conduisant à une excellente uniformité de teneur, de telle sorte que des comprimés peuvent être fabriqués en masse de manière économique et facile.
(KO)
본 발명은 정제 및 이의 제조방법에 관한 것으로, 아토르바스타틴 과립물의 입도분포를 일정 이상의 값이 되도록 조정하여 피마살탄과 정제화 과정에서 타정성이 현저히 향상되어 우수한 함량균일성을 나타낼 수 있어, 경제적으로 용이하게 대량 생산이 가능할 수 있다.
Latest bibliographic data on file with the International Bureau